Elucidate multidimensionality of type 1 diabetes mellitus heterogeneity by multifaceted information

被引:0
|
作者
Shaw-Ji Chen
Jen-Liang Cheng
Sheng-An Lee
Tse-Yi Wang
Jyy-Yu Jang
Kuang-Chi Chen
机构
[1] Mackay Memorial Hospital,Department of Psychiatry
[2] Mackay Medical College,Department of Medicine
[3] Tzu Chi University,Department of Medical Informatics
[4] Kainan University,Department of Health Industry Management
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Type 1 diabetes (T1D) is an autoimmune disease. Different factors, including genetics and viruses may contribute to T1D, but the causes of T1D are not fully known, and there is currently no cure. The advent of high-throughput technologies has revolutionized the field of medicine and biology, and analysis of multi-source data along with clinical information has brought a better understanding of the mechanisms behind disease pathogenesis. The aim of this work was the development of a data repository linking clinical information and interactome studies in T1D. To address this goal, we analyzed the electronic health records and online databases of genes, proteins, miRNAs, and pathways to have a global view of T1D. There were common comorbid diseases such as anemia, hypertension, vitreous diseases, renal diseases, and atherosclerosis in the phenotypic disease networks. In the protein–protein interaction network, CASP3 and TNF were date-hub proteins involved in several pathways. Moreover, CTNNB1, IGF1R, and STAT3 were hub proteins, whereas miR-155-5p, miR-34a-5p, miR-23-3p, and miR-20a-5p were hub miRNAs in the gene-miRNA interaction network. Multiple levels of information including genetic, protein, miRNA and clinical data resulted in multiple results, which suggests the complementarity of multiple sources. With the integration of multifaceted information, it will shed light on the mechanisms underlying T1D; the provided data and repository has utility in understanding phenotypic disease networks for the potential development of comorbidities in T1D patients as well as the clues for further research on T1D comorbidities.
引用
收藏
相关论文
共 50 条
  • [31] Pathophysiology of type 1 diabetes mellitus
    Kolb, H
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 1999, 107 : S88 - S88
  • [32] Immunogenetics of type 1 diabetes mellitus
    Morran, Michael P.
    Vonberg, Andrew
    Khadra, Anmar
    Pietropaolo, Massimo
    MOLECULAR ASPECTS OF MEDICINE, 2015, 42 : 42 - 60
  • [33] Treatment of diabetes mellitus type 1
    Martin, S.
    Dreyer, M.
    Kiess, W.
    Lueddeke, H. -J.
    Mueller, U. A.
    Schatz, H.
    Waldhaeusl, W.
    DIABETOLOGIE UND STOFFWECHSEL, 2007, 2 : S171 - S172
  • [34] Epigenetics in Type 1 Diabetes Mellitus
    Montagnana, Martina
    Lippi, Giuseppe
    Danese, Elisa
    BIOCHIMICA CLINICA, 2018, 42 (02) : 97 - 102
  • [35] Hypoglycemia in Type 1 Diabetes Mellitus
    Cryer, Philip E.
    ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2010, 39 (03) : 641 - +
  • [36] Genetics of type 1 diabetes mellitus
    F Pociot
    M F McDermott
    Genes & Immunity, 2002, 3 : 235 - 249
  • [37] MicroRNAs and Diabetes Mellitus Type 1
    Bahreini, Farbod
    Rayzan, Elham
    Rezaei, Nima
    CURRENT DIABETES REVIEWS, 2022, 18 (02)
  • [38] Genetik des Diabetes mellitus Typ 1 Genetics of type 1 diabetes mellitus
    K. Badenhoop
    Monatsschrift Kinderheilkunde, 2004, 152 : 1176 - 1182
  • [39] FULMINANT TYPE 1 DIABETES MELLITUS: A New Class of Type 1 Diabetes
    Shibasaki, Saeko
    Imagawa, Akihisa
    Hanafusa, Toshiaki
    DIABETES: AN OLD DISEASE, A NEW INSIGHT, 2013, 771 : 20 - 23
  • [40] Fulminant type 1 diabetes: A distinct subtype of type 1 diabetes mellitus
    Fu, Jiao
    Shi, Bing-Yin
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2013, 112 (06) : 363 - 364